BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 8145672)

  • 1. Aerosolized deoxyribonuclease for cystic fibrosis.
    Med Lett Drugs Ther; 1994 Apr; 36(920):34-5. PubMed ID: 8145672
    [No Abstract]   [Full Text] [Related]  

  • 2. What is the cystic fibrosis clinician supposed to do with human recombinant dornase alfa?
    Coates AL
    J Pediatr; 2001 Dec; 139(6):768-70. PubMed ID: 11743499
    [No Abstract]   [Full Text] [Related]  

  • 3. Where we are now with rhDNase.
    Geddes DM; Shah PL
    Lancet; 1999 May; 353(9166):1727. PubMed ID: 10347981
    [No Abstract]   [Full Text] [Related]  

  • 4. New treatment for cystic fibrosis.
    Kuhn RJ
    Am Pharm; 1994 Feb; NS34(2):16-8. PubMed ID: 8166040
    [No Abstract]   [Full Text] [Related]  

  • 5. Consensus conference: practical applications of Pulmozyme. September 22, 1993.
    Ramsey BW; Dorkin HL
    Pediatr Pulmonol; 1994 Jun; 17(6):404-8. PubMed ID: 8090614
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.
    Fuchs HJ; Borowitz DS; Christiansen DH; Morris EM; Nash ML; Ramsey BW; Rosenstein BJ; Smith AL; Wohl ME
    N Engl J Med; 1994 Sep; 331(10):637-42. PubMed ID: 7503821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis.
    Hubbard RC; McElvaney NG; Birrer P; Shak S; Robinson WW; Jolley C; Wu M; Chernick MS; Crystal RG
    N Engl J Med; 1992 Mar; 326(12):812-5. PubMed ID: 1538726
    [No Abstract]   [Full Text] [Related]  

  • 8. [New pharmacological approaches: rhDNase].
    Tournier G; Sardet A; Grosskopf C; Baculard A; Delaisi B
    Rev Pneumol Clin; 1995; 51(3):193-200. PubMed ID: 7569583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aerosolized dornase alfa (rhDNase) for therapy of cystic fibrosis.
    Hodson ME
    Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 2):S70-4. PubMed ID: 7881698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nebulised bronchodilators, antibiotics and rhDNase for children with cystic fibrosis.
    Spencer DA
    Thorax; 1997 Apr; 52 Suppl 2(Suppl 2):S89-91. PubMed ID: 9155860
    [No Abstract]   [Full Text] [Related]  

  • 11. Nebulised bronchodilators, corticosteroids, and rhDNase in adult patients with cystic fibrosis.
    Conway SP; Watson A
    Thorax; 1997 Apr; 52 Suppl 2(Suppl 2):S64-8. PubMed ID: 9155855
    [No Abstract]   [Full Text] [Related]  

  • 12. [2 significant stages in the management of mucoviscidosis: the French experience with dornase alfa (Pulmozyme) and the impact in international registries].
    Brémont F; Navarro J
    Arch Pediatr; 1998 Apr; 5(4):367-70. PubMed ID: 9759154
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pulmozyme (Dornase alfa)].
    Töglhofer W
    Wien Klin Wochenschr; 1994; 106(8):253-6. PubMed ID: 8023518
    [No Abstract]   [Full Text] [Related]  

  • 14. Statistical analysis of the long-term effects of recombinant human deoxyribonuclease on pulmonary function in cystic fibrosis patients.
    Chen JJ; Hamilton SA
    J Biopharm Stat; 2000 Aug; 10(3):287-97. PubMed ID: 10959912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aerosolized dornase alpha (rhDNase) in cystic fibrosis.
    Bates RD; Nahata MC
    J Clin Pharm Ther; 1995 Dec; 20(6):313-5. PubMed ID: 8847368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cystic fibrosis. Current indications for nebulized treatments: antibiotics and DNase].
    Sardet-Frismand A
    Rev Mal Respir; 1999 Jan; 16 Suppl 3():S131-2. PubMed ID: 10088286
    [No Abstract]   [Full Text] [Related]  

  • 17. [Perspective of use of rhDNase and new therapeutics for cystic fibrosis].
    Navarro J; Munck A
    Arch Pediatr; 1995 Jul; 2(7):682-4. PubMed ID: 7663661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aerosolized recombinant human DNase I for the treatment of cystic fibrosis.
    Shak S
    Chest; 1995 Feb; 107(2 Suppl):65S-70S. PubMed ID: 7842816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group.
    O'Donnell AE; Barker AF; Ilowite JS; Fick RB
    Chest; 1998 May; 113(5):1329-34. PubMed ID: 9596315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current therapeutic agents: dornase alfa].
    Baran D; Sternon J
    Rev Med Brux; 1997 Feb; 18(1):37-40. PubMed ID: 9132917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.